Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...
Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors ...
Roche's core research spans five large areas. Boris Zaïtra, who now leads corporate business development, is confident his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback